Evidence map›Paper›PMID 27888371›Full record

ArticleMarine biotechnology (New York, N.Y.)2016

Protective Effect of the Sulfated Agaran Isolated from the Red Seaweed Laurencia aldingensis Against Toxic Effects of the Venom of the Snake, Lachesis muta.

Ana Cláudia Rodrigues da Silva, Luciana Garcia Ferreira, Maria Eugênia Rabello Duarte, Mutue Toyota Fujii, Eladio Flores Sanchez, Miguel Daniel Noseda, André Lopes Fuly

Abstract read
PubMed Publisher
In one paragraph

Article in Marine biotechnology (New York, N.Y.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. The Protective Action ofBioMed research international · 2024
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Ana Cláudia Rodrigues da SilvaDepartment of Molecular and Cellular Biology, Federal Fluminense University, Niterói, Rio de Janeiro, CEP 24020-141, Brazil.
Luciana Garcia FerreiraDepartment of Biochemistry and Molecular Biology, Federal University of Paraná, Curitiba, Paraná, CEP 81531-980, Brazil.
Maria Eugênia Rabello DuarteDepartment of Biochemistry and Molecular Biology, Federal University of Paraná, Curitiba, Paraná, CEP 81531-980, Brazil. eugenia.duarte@pq.cnpq.br.
Mutue Toyota FujiiSecretary of São Paulo State for Environment, Institute of Botany, São Paulo, SP, CEP 04301-012, Brazil.
Eladio Flores SanchezLaboratory of Biochemistry of Proteins from Animal Venoms, Research and Development Center, Ezequiel Dias Foundation, Belo Horizonte, Minas Gerais, CEP 30510-010, Brazil.
Miguel Daniel NosedaDepartment of Biochemistry and Molecular Biology, Federal University of Paraná, Curitiba, Paraná, CEP 81531-980, Brazil.
André Lopes FulyDepartment of Molecular and Cellular Biology, Federal Fluminense University, Niterói, Rio de Janeiro, CEP 24020-141, Brazil. andrefuly@id.uff.br.
Universidade Federal do Paraná · BRUniversidade Federal Fluminense · BREzequiel Dias Foundation · BRInstituto de Botânica · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Snakebite is a serious occupational hazard affecting mainly rural populations of tropical and subtropical developing countries. Lachesis muta (Bushmaster) bites are extremely serious but are rarely reported in the literature. Bushmaster envenomings are characterized by intense local pain, edema, neurotoxicity, hypotension, local hemorrhage, and dramatic systemic alterations. Antivenom treatment has regularly been used for more than a century; however, it fails to neutralize local tissue damage and hemorrhage, leading to morbidity or disabilities in victims. Thus, the production and clinical use of antivenom must be improved. The present work characterizes, for the first time, a sulfated polysaccharide from the red seaweed, Laurencia aldingensis, including its neutralizing effect on some toxic activities of L. muta venom. Chemical and spectroscopic analyses showed that L. aldingensis produces sulfated agarans with the A-units partially C-2 sulfated or 6-O-methoxylated presetting the B-units in the cyclized (3,6-anhydro-α-L-galactose) or in the non-cyclized form (α-L-galactose). The latter is significantly substituted by sulfate groups on C-6. In vitro and in vivo assays showed that this sulfated agaran inhibited hemolysis, coagulation, proteolysis, edema, and hemorrhage of L. muta venom. Neutralization of hemorrhagic activity was also observed when the agaran was administered by different routes and after or before the venom injection. Furthermore, the agaran blocked the edema caused by a phospholipase A

Indexed as

AnimalsAntiveninsBlood CoagulationEdemaHemolysisHemorrhageHumansLaurenciaMicePhospholipases A2Plant ExtractsPolysaccharidesProteolysisSeaweedSnake BitesSulfatesAntiveninsPhospholipases A2Plant ExtractsPolysaccharidesSulfatesViper VenomsAntivenom treatmentChemical structureLachesis mutaLaurencia aldingensisSnake venomSulfated agaran

Identifiers

PMID27888371
OpenAlexW2553044866

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.